BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38333217)

  • 21. [Neoadjuvant chemoradiotherapy combined with surgery versus direct surgery in the treatment of Siewert type II and III adenocarcinomas of the esophagogastric junction: long-term prognostic analysis of a prospective randomized controlled trial].
    Tian Y; Wang Q; Wang J; Qiao XY; Zhang J; Lin YC; Li Y; Fan LQ; Yang PG; Zhao Q
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):128-137. PubMed ID: 33508918
    [No Abstract]   [Full Text] [Related]  

  • 22. [Efficacy comparison of laparoscopic versus open distal gastrectomy with D2 lymph dissection for advanced gastric cancer].
    Li Z; Shi Y; Zhao Y; Qian F; Hao Y; Tang B; Luo H; Wan Y; Yu P
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 May; 19(5):530-4. PubMed ID: 27215520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effects of robotic and laparoscopic-assisted surgery on lymph node dissection and short-term outcomes in patients with Siewert II adenocarcinoma of esophagogastric junction].
    Wang D; Cao S; Tan X; Liu S; Liu X; Niu Z; Chen D; Wang D; Zhang J; Lv L; Li Y; Jiang H; Guo D; Li Y; Li Z; Zhou Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):156-163. PubMed ID: 30799538
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oncological outcomes of laparoscopic versus open radical total gastrectomy for upper-middle gastric cancer after neoadjuvant chemotherapy: a study of real-world data.
    Zheng HL; Shen LL; Xu BB; Chen QY; Lu J; Xue Z; Jia-Lin ; Xie JW; Li P; Huang CM; Zheng CH
    Surg Endosc; 2023 Aug; 37(8):6288-6297. PubMed ID: 37198408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Early postoperative complications and risk factors in laparoscopic D2 radical gastrectomy for gastric cancer].
    Cai M; Zeng XY; Xiong Z; Gao JB; Shuai XM; Cai KL; Wang JL; Wang Z; Zhang P; Liu XH; Bai J; Cheng J; Wang GB; Tao KX
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Aug; 22(8):742-747. PubMed ID: 31422612
    [No Abstract]   [Full Text] [Related]  

  • 26. [A multi-center retrospective study of perioperative chemotherapy for gastric cancer based on real-world data].
    Ding XW; Zheng ZC; Zhao Q; Zhai G; Liang H; Wu X; Zhu ZG; Wang HJ; He QS; He XL; Du YA; Chen LC; Hua YW; Huang CM; Xue YW; Zhou Y; Zhou YB; Wu D; Fang XD; Dai YG; Zhang HW; Cao JQ; Li LP; Chai J; Tao KX; Li GL; Jie ZG; Ge J; Xu ZF; Zhang WB; Li QY; Zhao P; Ma ZQ; Yan ZL; Zheng GL; Yan Y; Tang XL; Zhou X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 May; 24(5):403-412. PubMed ID: 34000769
    [No Abstract]   [Full Text] [Related]  

  • 27. [Efficacy of laparoscopic proximal gastrectomy with double-tract reconstruction versus laparoscopic total gastrectomy with Roux-en-Y reconstruction for early upper gastric cancer].
    Qiu GL; Wei C; Zhu MK; Han SN; Li XW; Wang HJ; Wang PX; Liu JH; Zhou HY; Liao XH; Che XM; Fan L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 May; 25(5):412-420. PubMed ID: 35599396
    [No Abstract]   [Full Text] [Related]  

  • 28. Neoadjuvant chemoradiotherapy followed by D2 gastrectomy in locally advanced gastric cancer.
    Kim MS; Lim JS; Hyung WJ; Lee YC; Rha SY; Keum KC; Koom WS
    World J Gastroenterol; 2015 Mar; 21(9):2711-8. PubMed ID: 25759540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Laparoscopic versus open gastrectomy for serosa-invasive gastric cancer: A single-center retrospective cohort study.
    Long D; Feng Q; Li ZS; Zhao YL; Qian F; Tang B; Chen J; Li PA; Shi Y; Yu PW
    Surgery; 2021 Jun; 169(6):1486-1492. PubMed ID: 33558067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Feasibility, safety and long-term efficacy of laparoscopic total gastrectomy combined with distal pancreaticosplenectomy for T4b gastric cancer].
    Zhou SN; Yang B; Tan JN; Huang J; Chen ZT; Zheng SY; Gao H; Zhang YC; Wen LQ; Han FH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Feb; 23(2):163-169. PubMed ID: 32074797
    [No Abstract]   [Full Text] [Related]  

  • 31. Weekly paclitaxel plus ramucirumab versus weekly nab-paclitaxel plus ramucirumab for unresectable advanced or recurrent gastric cancer with peritoneal dissemination refractory to first-line therapy-the P-SELECT trial (WJOG10617G)-a randomised phase II trial by the West Japan Oncology Group.
    Hirata K; Hamamoto Y; Ando M; Imamura CK; Yoshimura K; Yamazaki K; Hironaka S; Muro K
    BMC Cancer; 2020 Jun; 20(1):548. PubMed ID: 32532230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Quality of life after totally laparoscopic versus laparoscopic-assisted total gastrectomy: a retrospective cohort study with propensity score matching].
    Lin GT; Chen JY; Wu D; Lin JX; Huang CM
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Aug; 25(8):699-707. PubMed ID: 35970804
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical Efficacy and Safety of Nab-Paclitaxel plus Ramucirumab Therapy in Patients with Unresectable Advanced or Recurrent Gastric Cancer].
    Murakami K; Takeno A; Masuzawa T; Imada A; Takase K; Toya K; Yukawa Y; Kawai K; Sakamoto T; Katsura Y; Ohmura Y; Kagawa Y; Hata T; Takeda Y; Murata K
    Gan To Kagaku Ryoho; 2020 Mar; 47(3):493-495. PubMed ID: 32381926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A phase II study of perioperative treatment in gastric cancer with No.16a2/b1 lymph node metastasis: DRAGON-06 trial.
    Lu S; Chen YG; Liu XW; Yang ZY; Shi M; Yuan H; Liu WT; Ni ZT; Yao XX; Hua ZC; Feng RH; He CY; Zheng YN; Wang ZQ; Sah BK; Chen MM; Zhu ZL; Li C; Zhang J; Yan M; Xia JZ; Zhu ZG; Yan C
    Future Oncol; 2022 Dec; 18(39):4239-4349. PubMed ID: 36651765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A comparative study on short-term outcomes and quality of life for gastric cancer patients between totally laparoscopic total gastrectomy using an endoscopic linear stapler and laparoscopic-assisted total gastrectomy using a circular stapler].
    Hu P; Liang WQ; Xi HQ; Zhang KC; Cui JX; Chen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Feb; 25(2):157-165. PubMed ID: 35176828
    [No Abstract]   [Full Text] [Related]  

  • 36. [Postoperative complications and their influence on the prognosis factors in gastric cancer patients receiving neoadjuvant treatment].
    Wang TB; Mao QK; Zhang XJ; Zhou H; Guo CG; Chen YT; Zhao DB
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):160-166. PubMed ID: 33508922
    [No Abstract]   [Full Text] [Related]  

  • 37. Learning curve and long-term outcomes of laparoscopy-assisted distal gastrectomy for gastric cancer.
    Hu WG; Ma JJ; Zang L; Xue P; Xu H; Wang ML; Lu AG; Li JW; Feng B; Zheng MH
    J Laparoendosc Adv Surg Tech A; 2014 Jul; 24(7):487-92. PubMed ID: 24933012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retrospective cohort study of nanoparticle albumin-bound paclitaxel plus ramucirumab versus paclitaxel plus ramucirumab as second-line treatment in patients with advanced gastric cancer.
    Okunaka M; Kotani D; Demachi K; Kawazoe A; Yoshino T; Kawasaki T; Shitara K
    BMC Cancer; 2020 Nov; 20(1):1111. PubMed ID: 33198652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does three-dimensional surgery affect recurrence patterns in patients with gastric cancer after laparoscopic R0 gastrectomy? Results from a 3-year follow-up phase III trial.
    Lu J; Xu BB; Zheng ZF; Xie JW; Wang JB; Lin JX; Chen QY; Cao LL; Lin M; Tu RH; Huang ZN; Zheng CH; Huang CM; Li P
    Surg Endosc; 2021 Jan; 35(1):113-123. PubMed ID: 31953725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcome of laparoscopy-assisted gastrectomy vs. open gastrectomy for gastric cancer: a retrospective comparative study.
    Chen WJ; Xu CY; Shen JG; Xie SD; Yuang XM; Wang L
    Hepatogastroenterology; 2012 May; 59(115):938-41. PubMed ID: 22057373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.